September 23, 2012

World Pharmacy and India

Edited by Hans Löfgren

The pharmaceutical industry presents one of India’s most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries.  Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals.

The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India examines this important industry from different economic, social and political perspectives. Topics covered include the implications of TRIPS-compliant intellectual property rights, the role of flexibilities under TRIPS, the market regulation system, the role of Indian firms in exporting HIV/AIDS medications to Africa, the issue of free trade agreements, the power and reach of foreign pharmaceutical multinationals in India’s domestic market, and the sustainability of India as a major generics supplier.

Hans Lofgren is Associate Professor in Politics and Policy Studies, Deakin University, Melbourne, Australia. His publications include,  with  P. Sarangi (eds) The Politics and Culture of Globalisation: India and Australia (Social Science Press, New Delhi, 2009); with M. Leahy & E. de Leeuw (eds) Democratising Health: Consumer Groups in the Policy Process (Edward Elgar, 2011).


1.     The Pharmaceutical Industry and Access to Medicines in India: An Introduction
- Hans Lofgren

2.      Challenges of Regulation of Medicines in India -  Chinu Srinivasan & Anant Phadke

3.      CIPLA : Patients over Patents -  Neelam Raaj

4.       Systemic Failure of Regulation: The Political Economy of Pharmaceutical and Bulk Drug Manufacturing - G. Vijay

5.      TRIPS Flexibilities and Access to Patented Medicines in India -  Narayanan Lalitha

6.      India’s Free Trade Agreements : Implications for Access to Medicines in India and the Global South - Kajal Bhardwaj

7.       At any price? Boehringer Ingelheim, Bayer HealthCare and Baxter in India -  Christiane Fischer and Claudia Jenkes

8.       Trends and Prospects for India as a Global Generic Player -  Deepak Kumar Jena & Poduri Balaram

9.      The Indian Patent Law and Access to Antiretroviral Drugs in Sub-Saharan Africa -  Christiane Fischer

10.   Accessing Medicines in Developing Economies through Competition Law -  Tu Thanh Nguyen

11.   The Politics of AIDS Treatment in Brazil: Patents and Access to Medicines -  André de Mello e Souza

12.    Financing Pharmaceutical Research and Development: Alternatives to the Patent System - Philip Soos and Hans Lofgren 

13.  Post-script - Hans Lofgren

364pp | 215x140 mm | Hardback
ISBN 978-81-87358-66-4
Pub date: Oct  2012

No comments: